论文部分内容阅读
目的:观察低分子肝素(LMWH)治疗短暂性脑缺血发作(TIA)的疗效及对患者血液流变学影响,方法;应用LMWH治疗38例TIA患者,进行临床及实验室指标观察并与对照组比较。结果:LMWH的基本治愈率、总有效率均明显高于对照组(P<0.01),血浆粘度、血小板聚集率明显,较治疗前改善(P<0.05)血小板计数、凝血酶时间、凝血酶原时间无明显并异,未发现明显副作用。结论:LMWH是治疗TIA的一种安全、有效的药物。
Objective: To observe the effect of low molecular weight heparin (LMWH) on the treatment of transient ischemic attack (TIA) and its effect on hemorheology in patients. Methods Thirty-eight patients with TIA were treated with LMWH. The clinical and laboratory indexes were observed and compared with the control Group comparison. Results: The basic cure rate and total effective rate of LMWH were significantly higher than that of the control group (P <0.01). The plasma viscosity and platelet aggregation rate were significantly improved (P <0.05), the platelet count, thrombin time, No significant differences in time, no significant side effects were found. Conclusion: LMWH is a safe and effective drug for the treatment of TIA.